Greetings!

In this issue, you will find summary of latest research articles by editorial team members. We have selected a few clinically relevant articles in each section hoping that they will be more useful for members.

All regular features are included and we have also given a drug update on recently FDA-approved phosphodiesterase inhibitor, Apremilast. 

Our expert for this issue is Dr Dinesh Khanna, who has discussed some very useful practical problems related to systemic sclerosis.

In previous month’s questionnaire-based survey, answers could not be submitted because of some technical problems.  We apologize for the same, and we have retained those questions along with this issue’s question for your reply.

It is our sincere appeal to all members to post their questions to us so that we can put those questions to experts for every one’s benefit.

We welcome your suggestions to improve this IRA activity. Please post your suggestions/comments on iraenewsleter@hotmail.com

Best Wishes,
Banwari Sharma,
Editor